Area of research
Genetics · Oncology
Research interest
Research interests include Glioma Diagnosis and Treatment, Brain Metastases and Treatment, Cancer Immunotherapy and Biomarkers, and CAR-T cell therapy research.
Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201
Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages
Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies
A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma